CTIS2023-508849-40-00招募中1 期
The efficacy of aprepitant for the prevention of postoperative nausea and vomiting after bariatric surgery. - PONVApr1
niversity Of Tartu0 个研究点目标入组 260 人开始时间: 2023年12月23日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 发起方
- 入组人数
- 260
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 65+（—）
- 性别
- All
入选标准
- •Patient is scheduled for bariatric surgery - LSG (laparoscopic sleeve gastrectomy),RYGB(Roux-en-Y) or OAGB(one-anastomosis MINI gastric bypass)., Patients are adult - 18 years or older., Patients have at least 2 risk factors for PONV - female sex, non-smokers, post-operative opioid analgesia, previous PONV and a duration of surgery longer than 1 hour., Obesity with a BMI more than 30.
排除标准
- •Revision bariatric surgery., Known intolerance to the study drug - aprepitant.
研究者
相似试验
招募中
3 期
Evaluation of the efficacy of Aprepitant in vomiting of children with cancerMalignant cancer.Agranulocytosis secondary to cancer chemotherapyD70.1IRCT20200204046377N1Shahid Beheshti University of Medical Sciences30
已完成
3 期
The safety and efficacy of Aprepitant to the prevention of chemotherapy-induced nausea and vomitingIRCT20200819048455N1Iran University of Medical Sciences85
招募中
Unknown
Investigating the effect of pancreatic duct stent in the prevention of pancreatitis after ERCPIRCT20230314057717N3Shahid Beheshti University of Medical Sciences238
尚未招募
不适用
TO Observe the effectiveness of prophylactic phenylephrine infusion versus therapeutic phenylephrine bolus on maternal hemodynamics and neonatal outcome during elective cesarean section.CTRI/2022/12/048156Swai mansingh medical college and hospital
招募中
不适用
Efficacy and safety of Aprepitant for the prevention of chemotherapy-induced nausea and vomiting in patients with hematological malignancies after highly emetogenic chemotherapyhematological malignanciesJPRN-UMIN000005624Tokushima University Hospital100